Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Frontier Biotech Enters into Agreement with GSK for siRNA Therapies

Thursday, February 26, 2026

Frontier Biotechnologies has entered into a global exclusive licensing agreement with GSK covering therapeutic applications based on small interfering RNA siRNA technology

China Launches Dual-Track Reimbursement System for Innovative Drugs to Boost Global Pharma Access

Wednesday, February 25, 2026

China has implemented a new dualtrack reimbursement system for innovative drugs accelerating market access and supporting global pharmaceutical manufacturers in the Asian region

Siren Biotechnology Receives FDA Fast Track Designation for SRN-101 for Recurrent High-Grade Glioma

Wednesday, February 25, 2026

Siren Biotechnology has received Fast Track Designation from the US Food and Drug Administration FDA for SRN its lead AAVbased immunogene therapy for the treatment of recurrent highgrade glioma HGG

Sciwind Biosciences Partners with Pfizer China to Commercialise its Biased GLP-1 in China

Wednesday, February 25, 2026

Hangzhou Sciwind Biosciences Co Ltd has entered into a strategic commercialisation agreement with Pfizer China for Ecnoglutide injection a nextgeneration cAMPbiased GLP receptor agonist

TIDES Asia 2026: Premier Summit on Oligonucleotide and Peptide Therapeutics Kicks Off in Tokyo Today

Tuesday, February 24, 2026

The TIDES Asia summit begins today in Tokyo uniting AsiaPacific biopharma leaders to advance oligonucleotide peptide mRNA and genome editing technologies

Formosa Pharmaceuticals Signs Licensing Deal with Arrotex for Commercialisation of Clobetasol Propionate Ophthalmic Suspension in Australia and New Zealand

Tuesday, February 24, 2026

Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Arrotex Pharmaceuticals Pty Ltd for the commercialisation of clobetasol propionate ophthalmic suspension APP in Australia and New Zealand The product is used to treat inf...

China Launches Dual-Track Reimbursement System for Innovative Drugs to Boost Global Pharma Access

Monday, February 23, 2026

China has introduced a dualtrack reimbursement system for innovative drugs creating new pathways for global pharmaceutical manufacturers to enter the market more efficiently

Teva and Medincell Receives FDA Acceptance for Once-Monthly Olanzapine Injection for Schizophrenia

Saturday, February 21, 2026

Teva Pharmaceutical Industries and Medincell have announced that the US Food and Drug Administration has accepted their New Drug Application NDA for TEV an investigational olanzapine extendedrelease injectable suspension

AstraZeneca’s CALQUENCE plus Venetoclax Approved in the US as First All-Oral Fixed-Duration Regimen for First-Line CLL

Saturday, February 21, 2026

AstraZeneca has received approval from the US Food and Drug Administration for CALQUENCE acalabrutinib in combination with venetoclax as a firstline treatment for adults with chronic lymphocytic leukaemia CLL and small lymphocytic lymphoma SLL

VivaMed BioPharma Enters into Partnership with Syngene International to Strengthen AI-driven Drug Repurposing Programmes

Friday, February 20, 2026

VivaMed BioPharma has entered into a strategic partnership with Syngene International to support the development and validation of therapeutic programmes identified through artificial intelligence AI